Jiangbing Zhou

6.7k total citations · 1 hit paper
78 papers, 4.7k citations indexed

About

Jiangbing Zhou is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Jiangbing Zhou has authored 78 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 20 papers in Biomaterials and 14 papers in Biomedical Engineering. Recurrent topics in Jiangbing Zhou's work include Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (14 papers) and Nanoplatforms for cancer theranostics (11 papers). Jiangbing Zhou is often cited by papers focused on Nanoparticle-Based Drug Delivery (19 papers), RNA Interference and Gene Delivery (14 papers) and Nanoplatforms for cancer theranostics (11 papers). Jiangbing Zhou collaborates with scholars based in United States, China and United Kingdom. Jiangbing Zhou's co-authors include W. Mark Saltzman, Toral Patel, Joseph M. Piepmeier, Peihua Gu, Jie Liu, Ying Zhang, Joseph B. Margolick, Zhaozhong Jiang, Zeming Chen and Ann T. Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Clinical Investigation.

In The Last Decade

Jiangbing Zhou

77 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance

2007 539 citations Jiangbing Zhou, Julia Wulfkuhle et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jiangbing Zhou

Since Specialization

Citations

This map shows the geographic impact of Jiangbing Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangbing Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangbing Zhou more than expected).

Fields of papers citing papers by Jiangbing Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiangbing Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangbing Zhou. The network helps show where Jiangbing Zhou may publish in the future.

Co-authorship network of co-authors of Jiangbing Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jiangbing Zhou. A scholar is included among the top collaborators of Jiangbing Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiangbing Zhou. Jiangbing Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Signal Transducer Nanoparticles Enable Siglec‐10/G Blockade Immunotherapy for Breast Cancer Treatment 2025 ·Advanced Materials ·Zhouqi Meng, Xingchun Gao, Xiangjun Tang, Jiang Fan, Wendy C. Sheu, Zewei Tu, (unknown), (unknown), Lizhong Wang, Runhua Liu, Jiangbing Zhou	1
2	Autocatalytic, Brain Tumor‐Targeting Delivery of Bardoxolone Methyl Self‐Assembled Nanoparticles for Glioblastoma Treatment 2024 ·SHILAP Revista de lepidopterología ·Zhang Ye, Wendy C. Sheu, (unknown), (unknown), Jia Liu, Zhang Li, Fanen Yuan, (unknown), Jiangbing Zhou, Qianxue Chen, Xuan Xiao, Shenqi Zhang	2
3	Self‐Assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma 2023 ·CNS Neuroscience & Therapeutics ·(unknown), Qingyu Zhao, Xinyi Zhu, Long Zhou, Ping Song, Baohui Liu, Daofeng Tian, Qianxue Chen, Jiangbing Zhou, (unknown)	17
4	ZNF117 regulates glioblastoma stem cell differentiation towards oligodendroglial lineage 2022 ·Nature Communications ·Jun Liu, Xiaoying Wang, Ann T. Chen, Xingchun Gao, Benjamin Himes, Hongyi Zhang, Zeming Chen, Jianhui Wang, Wendy C. Sheu, Gang Deng, Yang Xiao, (unknown), Shenqi Zhang, Fuyao Liu, Yong Zhu, Rong Fan, Toral Patel, W. Mark Saltzman, Jiangbing Zhou	25
5	Inhibition of NETosis by a Nuclear-Penetrating Anti-DNA Autoantibody 2022 ·ImmunoHorizons ·Xiaoyong Chen, (unknown), Valentina Dubljevic, (unknown), Jiangbing Zhou, James A. Campbell, (unknown), Kim M. O’Sullivan, James E. Hansen	7
6	Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer 2022 ·Oncogene ·Chao Wang, (unknown), Chao Zhang, Zhichao Liu, (unknown), Yicun Wang, Guangxin Zhang, Shuaibin Wang, Xuelian Cui, Yue Zhang, Sejong Bae, Jiangbing Zhou, Lizhong Wang, Runhua Liu	12
7	Targeted Delivery of Chemo‐Sonodynamic Therapy via Brain Targeting, Glutathione‐Consumable Polymeric Nanoparticles for Effective Brain Cancer Treatment 2022 ·Advanced Science ·Haoan Wu, Xingchun Gao, Yuanyuan Luo, (unknown), (unknown), Zhaozhong Jiang, Jiangbing Zhou	42
8	ENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody 2021 ·JCI Insight ·Zahra Rattray, Gang Deng, Shenqi Zhang, (unknown), Christopher May, Xiaoyong Chen, (unknown), Jun Liu, (unknown), Nicholas J. W. Rattray, Caroline H. Johnson, Valentina Dubljevic, James A. Campbell, Anita Hüttner, Joachim M. Baehring, Jiangbing Zhou, James E. Hansen	10
9	Phytonanomaterials as therapeutic agents and drug delivery carriers 2021 ·Advanced Drug Delivery Reviews ·Ying Xie, Chao Ma, Xin Yang, Jiacheng Wang, (unknown), Jiangbing Zhou	18
10	Targeted disruption of tumor vasculature via polyphenol nanoparticles to improve brain cancer treatment 2021 ·Cell Reports Physical Science ·Fuyao Liu, (unknown), Miao Li, Junning Ma, Gang Deng, Shenqi Zhang, Wendy C. Sheu, (unknown), Haoan Wu, Jun Liu, Ann T. Chen, Farrah S. Mohammed, Jiangbing Zhou	23
11	Mutation-Directed Therapeutics for Neurofibromatosis Type I 2020 ·Molecular Therapy — Nucleic Acids ·André Leier, David M. Bedwell, Ann T. Chen, George Dickson, Kim M. Keeling, Robert A. Kesterson, Bruce R. Korf, (unknown), Ulrich F. Müller, Linda Popplewell, Jiangbing Zhou, Deeann Wallis	22
12	Generation of Ultra-Small PLGA Nanoparticles by Sequential Centrifugation 2018 ·Methods in molecular biology ·Xingwang Wu, Jiangbing Zhou, Toral Patel	2
13	pH-Responsive fluorescent graphene quantum dots for fluorescence-guided cancer surgery and diagnosis 2017 ·Nanoscale ·Zetan Fan, Shixin Zhou, César A. Garcia, Louzhen Fan, Jiangbing Zhou	126
14	Multi-layered nanoparticles for combination gene and drug delivery to tumors 2014 ·Biomaterials ·Asiri Ediriwickrema, Jiangbing Zhou, Yang Deng, W. Mark Saltzman	52
15	Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma 2013 ·Proceedings of the National Academy of Sciences ·Jiangbing Zhou, Toral Patel, Rachael W. Sirianni, Garth W. Strohbehn, Ming‐Qiang Zheng, (unknown), (unknown), Anita Hüttner, Yiyun Huang, Richard E. Carson, Ying Zhang, David Sullivan, Joseph M. Piepmeier, W. Mark Saltzman	225
16	Effects of dioscin extracted from polygonatum zanlanscianense pamp on several human tumor cell lines 2012 ·Tsinghua Science & Technology ·Zhao Wang, Jiangbing Zhou, (unknown), (unknown), Hongjun Zhang	1
17	Methionine Aminopeptidases from Mycobacterium tuberculosis as Novel Antimycobacterial Targets 2010 ·Chemistry & Biology ·Omonike A. Olaleye, Tirumalai R. Raghunand, Shridhar Bhat, (unknown), Sandeep Tyagi, Gyanu Lamichhane, Peihua Gu, Jiangbing Zhou, Ying Zhang, J Grosset, William R. Bishai, Jun O. Liu	53
18	Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance breakdown → 2007 ·Proceedings of the National Academy of Sciences ·Jiangbing Zhou, Julia Wulfkuhle, Hao Zhang, Peihua Gu, Yanqin Yang, Jianghong Deng, Joseph B. Margolick, Lance A. Liotta, Emanuel Petricoin, Ying Zhang	539
19	NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells 2007 ·Breast Cancer Research and Treatment ·Jiangbing Zhou, Hao Zhang, Peihua Gu, Jining Bai, Joseph B. Margolick, Ying Zhang	167
20	PURIFICATION AND CHARACTERIZATION OF THE TOXIN OF Phytophthora nicotianae 1987 ·科学通报(英文版) ·(unknown), Jiangbing Zhou	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact